Short Interest in Elekta AB (OTCMKTS:EKTAY) Declines By 45.6%

Elekta AB (OTCMKTS:EKTAY) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 3,337 shares, a decrease of 45.6% from the August 15th total of 6,134 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 6,268 shares, the short-interest ratio is presently 0.5 days.

Elekta Trading Up 1.9%

Shares of EKTAY stock opened at $5.11 on Tuesday. The business’s 50 day moving average is $5.26 and its two-hundred day moving average is $5.64. Elekta has a twelve month low of $4.35 and a twelve month high of $6.93. The company has a market capitalization of $1.88 billion, a P/E ratio of -42.58 and a beta of 1.05. The company has a current ratio of 0.87, a quick ratio of 0.68 and a debt-to-equity ratio of 0.47.

Elekta (OTCMKTS:EKTAY) last released its quarterly earnings results on Thursday, August 27th. The company reported $0.07 EPS for the quarter. Elekta had a positive return on equity of 13.31% and a negative net margin of 2.38%.The business had revenue of $372.30 million during the quarter. Equities analysts forecast that Elekta will post 0.43 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 28th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold”.

Elekta Company Profile

Elekta AB is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system.

Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software.